Drug Watch. AIDS, HIV infection, and related complications.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 344
- Publication type:
- Article
Works matching IS 1082801X AND DT 2011 AND VI 46 AND IP 8
Results: 12
1
2
Policy Watch. FDA maps strategy to deal with rising drug imports, counterfeiting, and other global threats.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 342
- By:
- Publication type:
- Article
3
Treatment of chronic hepatitis C: The new standard of care for the future.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 314
- By:
- Publication type:
- Article
4
Medication Safety and Reliability. FDA imposes new contraindications, restrictions, and dose limitations on simvastatin.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 313
- Publication type:
- Article
5
Medication Safety and Reliability. FDA warns 5-ARIs may increase the risk of high-grade prostate cancer.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 313
- Publication type:
- Article
6
Fidaxomicin: New therapy for Clostridium difficile-associated diarrhea.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 297
- By:
- Publication type:
- Article
7
App Watch. Growth of mobile medical apps prompts FDA to seek input on proposed oversight approach.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 295
- By:
- Publication type:
- Article
8
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 294
- Publication type:
- Article
9
FDA Drug Approvals. First-time generic approvals.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 294
- Publication type:
- Article
10
FDA Drug Approval. New molecular entities: Tradjenta.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 293
- Publication type:
- Article
11
FDA Drug Approvals. New molecular entities: Victrelis.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 293
- Publication type:
- Article
12
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 8, p. 293
- Publication type:
- Article